Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04593563
Recruitment Status : Active, not recruiting
First Posted : October 20, 2020
Last Update Posted : October 15, 2021
Information provided by (Responsible Party):
Maryland Oncology Hematology, PA

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : October 2022
Estimated Study Completion Date : October 2023